Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT02243436 · COMPLETED
Trial details
- NCT number
- NCT02243436
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-11
- Primary completion
- 2019-01-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.